NCT05083325View on ClinicalTrials.gov

Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

October 10, 2021

Study Completion Date

October 10, 2021

Conditions
Bioequivalence
Interventions
DRUG

Oseltamivir 75mg Test Drug capsules

Investigational Medicinal Product

DRUG

Oseltamivir 75mg capsules Reference Product capsules

Tamiflu (Roche Pharma (Switzerland) AG, Basel)

Trial Locations (1)

600048

Azidus Laboratories Ltd., Chennai

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT05083325 - Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter